Epidemiological Analysis of Hospitalized Patients with Severe Complicated Influenza in Taiwan: A Retrospective Review from 2010 to 2020 - Scorecard - MDSpire

Epidemiological Analysis of Hospitalized Patients with Severe Complicated Influenza in Taiwan: A Retrospective Review from 2010 to 2020

  • By

  • Yu-Huei Wei

  • Fu-Huang Lin

  • Chi-Jeng Hsieh

  • Yu-Ching Chou

  • Chia-Peng Yu

  • March 10, 2026

  • 0 min

Share

Clinical Scorecard: Epidemiological Analysis of Hospitalized Patients with Severe Complicated Influenza in Taiwan: A Retrospective Review from 2010 to 2020

At a Glance

CategoryDetail
ConditionSevere complicated influenza infection requiring hospitalization
Key MechanismsInfluenza virus infection primarily transmitted via respiratory droplets and contact; influenza A virus subtypes cause pandemics; complications include pneumonia, encephalitis, myocarditis
Target PopulationHospitalized patients with laboratory-confirmed severe complicated influenza in Taiwan, including high-risk groups such as elderly (>65 years), infants, pregnant women, immunocompromised, and those with chronic diseases
Care SettingHospital inpatient care with laboratory confirmation and surveillance reporting

Key Highlights

  • Influenza causes significant morbidity and mortality globally, with seasonal epidemics and occasional pandemics mainly due to influenza A virus subtypes.
  • Severe complicated influenza includes pneumonia, neurologic symptoms, and myopericarditis, requiring hospitalization and laboratory confirmation.
  • Taiwan has a national surveillance system (TNNDSS) for severe complicated influenza cases, facilitating epidemiological monitoring and reporting.

Guideline-Based Recommendations

Diagnosis

  • Laboratory confirmation via viral culture, immunofluorescence staining, RT-PCR, or rapid diagnostic tests from respiratory specimens.
  • Case definition includes community-onset, laboratory-confirmed influenza with evidence of severe complications such as pneumonia or neurologic symptoms.

Management

  • Hospitalization for severe complicated influenza cases.
  • Supportive care and treatment of complications such as pneumonia, encephalitis, and myocarditis.

Monitoring & Follow-up

  • National surveillance through TNNDSS for reporting and tracking severe influenza cases.
  • Monitoring of epidemiological trends and demographic data to inform public health responses.

Risks

  • Higher risk of severe illness and death in elderly (>65 years), infants, pregnant women, immunocompromised individuals, and patients with chronic diseases or obesity (BMI ≥ 30 kg/m2).
  • Potential for rapid outbreaks and extensive spread during epidemics and pandemics.

Patient & Prescribing Data

Hospitalized patients with severe complicated influenza in Taiwan from 2010 to 2020

Most patients recover without treatment; however, severe cases require hospitalization and management of complications. Regular influenza vaccination is the most effective preventive measure.

Clinical Best Practices

  • Implement routine influenza vaccination, especially in high-risk populations, to prevent severe complications.
  • Use laboratory confirmation for accurate diagnosis of influenza and its complications.
  • Maintain national surveillance systems to monitor severe influenza cases and guide public health interventions.
  • Provide prompt hospitalization and supportive care for patients with severe complicated influenza.

Related Resources & Content

Original Source(s)

Related Content